000			02014 a2200541 4500
005			20250515122355.0
264		0	_c20080918
008			200809s 0 0 eng d
022			_a1521-0111
024	7		_a10.1124/mol.108.047787 _2doi
040			_aNLM _beng _cNLM
100	1		_aGálvez-Peralta, Marina
245	0	0	_aOvercoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemcitabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carcinoma cell lines. _h[electronic resource]
260			_bMolecular pharmacology _cSep 2008
300			_a724-35 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCamptothecin _xanalogs & derivatives
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aCheckpoint Kinase 1
650	0	4	_aDNA, Neoplasm _xbiosynthesis
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDown-Regulation _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aDrug Screening Assays, Antitumor
650	0	4	_aDrug Synergism
650	0	4	_aHumans
650	0	4	_aIrinotecan
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Kinases _xmetabolism
650	0	4	_aProtein Processing, Post-Translational _xdrug effects
650	0	4	_aRNA, Small Interfering _xmetabolism
650	0	4	_aS Phase _xdrug effects
650	0	4	_aTumor Stem Cell Assay
650	0	4	_aGemcitabine
700	1		_aDai, Nga T
700	1		_aLoegering, David A
700	1		_aFlatten, Karen S
700	1		_aSafgren, Stephanie L
700	1		_aWagner, Jill M
700	1		_aAmes, Matthew M
700	1		_aKarnitz, Larry M
700	1		_aKaufmann, Scott H
773	0		_tMolecular pharmacology _gvol. 74 _gno. 3 _gp. 724-35
856	4	0	_uhttps://doi.org/10.1124/mol.108.047787 _zAvailable from publisher's website
999			_c18002353 _d18002353